Eledon Pharmaceuticals, Inc. (ELDN) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$2.84
Day's range
$3.1

Eledon Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BVF INC/IL 08/14/2026 6.29 M $24.80 M   0.00% 5.60%
BLACKROCK, INC. 08/07/2026 5.12 M $20.19 M   16.92% 4.56%
DEFILADE CAPITAL MANAGEMENT, L.P. 08/14/2026 3.53 M $13.89 M   -1.09% 3.14%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 3.42 M $13.46 M   3.77% 3.04%
GOLDMAN SACHS GROUP INC 08/14/2026 2.51 M $9.89 M   578.30% 2.23%
ENSIGN PEAK ADVISORS, INC 08/14/2026 2.10 M $8.28 M   -14.75% 1.87%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 1.96 M $7.71 M   9.20% 1.74%
CATALIO CAPITAL MANAGEMENT, LP 08/14/2026 1.70 M $6.68 M   3.37% 1.51%
STATE STREET CORP 08/07/2026 1.62 M $6.39 M   40.47% 1.44%
ZIMMER PARTNERS, LP 08/14/2026 1.60 M $6.29 M   -14.85% 1.42%
SPHERA FUNDS MANAGEMENT LTD. 08/14/2026 1.19 M $4.69 M   -32.78% 1.06%
AWM INVESTMENT COMPANY, INC. 08/14/2026 1.10 M $4.33 M   0.00% 0.98%
UBS GROUP AG 08/13/2026 1.05 M $4.13 M   91.48% 0.93%
KINGDON CAPITAL MANAGEMENT, L.L.C. 08/14/2026 1.04 M $4.09 M   0.00% 0.92%
MILLENNIUM MANAGEMENT LLC 08/14/2026 979.71 K $3.86 M   100.00% 0.87%
BANK OF AMERICA CORP /DE/ 08/14/2026 883.10 K $3.48 M   1.56% 0.79%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 647.81 K $2.55 M   -33.52% 0.58%
22NW, LP 08/14/2026 636.36 K $2.51 M   0.00% 0.57%
NORTHERN TRUST CORP 08/13/2026 616.40 K $2.43 M   13.34% 0.55%
AQR CAPITAL MANAGEMENT LLC 08/14/2026 581.03 K $2.29 M   236.99% 0.52%
CM MANAGEMENT, LLC 08/13/2026 575.00 K $2.27 M   -11.54% 0.51%
BLUE OWL CAPITAL HOLDINGS LP 08/11/2026 566.51 K $2.23 M   -60.10% 0.50%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 538.74 K $2.12 M   703.12% 0.48%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 533.37 K $2.10 M   24.07% 0.47%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 528.96 K $2.08 M   5.00% 0.47%
MORGAN STANLEY 08/13/2026 485.09 K $1.91 M   234.18% 0.43%
BREVAN HOWARD CAPITAL MANAGEMENT LP 08/14/2026 304.71 K $1.17 M   33.32% 0.27%
TRIUMPH CAPITAL MANAGEMENT 07/21/2026 303.44 K $1.20 M   100.00% 0.27%
CITADEL ADVISORS LLC 08/14/2026 279.40 K $1.10 M   100.00% 0.25%
JANE STREET GROUP, LLC 08/14/2026 278.00 K $1.10 M   100.00% 0.25%
BIT CAPITAL GMBH 08/12/2026 266.00 K $1.05 M   98.51% 0.24%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 252.23 K $993.79 K   129.41% 0.22%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 248.30 K $978.30 K   100.00% 0.22%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 247.40 K $974.77 K   27.51% 0.22%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 247.40 K $974.77 K   100.00% 0.22%
CITADEL ADVISORS LLC 08/14/2026 215.97 K $850.93 K   100.00% 0.19%
NUVEEN, LLC 08/11/2026 209.10 K $823.84 K   174.07% 0.19%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 200.90 K $791.55 K   716.67% 0.18%
BANK OF NEW YORK MELLON CORP 08/06/2026 166.93 K $657.69 K   15.80% 0.15%
LPL FINANCIAL LLC 08/07/2026 111.70 K $440.08 K   49.01% 0.10%
JACOBS LEVY EQUITY MANAGEMENT, INC 08/14/2026 109.84 K $432.77 K   100.00% 0.10%
MAVEN SECURITIES LTD 08/14/2026 100.00 K $394.00 K   100.00% 0.09%
RHUMBLINE ADVISERS 08/12/2026 88.61 K $349.11 K   86.05% 0.08%
SIMPLEX TRADING, LLC 08/12/2026 88.60 K $349.07 K   100.00% 0.08%
PRODIGY ASSET MANAGEMENT LLC 07/07/2026 86.70 K $341.61 K   100.00% 0.08%
DAYTONA STREET CAPITAL LLC 08/03/2026 81.17 K $313.30 K   0.00% 0.07%
DEUTSCHE BANK AG\ 08/07/2026 76.64 K $301.97 K   -14.22% 0.07%
WELLS FARGO & COMPANY/MN 08/14/2026 74.94 K $295.28 K   104.94% 0.07%
ROCKEFELLER CAPITAL MANAGEMENT L.P. 08/13/2026 72.67 K $286.30 K   1.40% 0.06%
SUSQUEHANNA PORTFOLIO STRATEGIES, LLC 08/14/2026 71.92 K $283.36 K   609.82% 0.06%

Eledon Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 180 institutional investors and hedge funds held shares of Eledon Pharmaceuticals Inc. The most heavily invested institutionals were:

BVF INC/IL: 6.29 M

BlackRock, Inc.: 5.12 M

Defilade Capital Management, L.P.: 3.53 M

VANGUARD CAPITAL MANAGEMENT LLC: 3.42 M

GOLDMAN SACHS GROUP INC: 2.51 M

Ensign Peak Advisors, Inc: 2.1 M

41.90% of Eledon Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 51.42 M shares in the last 24 months. This purchase volume represents approximately $149.12 M in transactions.